Global Bio-chem Technology Group Company Limited
GBCMF
$0.005
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 46.11% | 184.33% | 454.39% | 839.41% | 10,364.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.11% | 184.33% | 454.39% | 839.41% | 10,364.06% |
| Cost of Revenue | 34.42% | 147.08% | 322.45% | 656.08% | 25,447.47% |
| Gross Profit | 400.99% | 954.41% | 371.34% | 492.01% | 452.90% |
| SG&A Expenses | -3.98% | 46.09% | 63.01% | 49.93% | 38.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 25.07% | -124.50% | -120.85% | -108.24% | -100.06% |
| Total Operating Expenses | 26.07% | 88.94% | 106.54% | 113.00% | 120.56% |
| Operating Income | 58.39% | 65.07% | 75.23% | 65.19% | 56.97% |
| Income Before Tax | -79.75% | 36.75% | 647.49% | 450.75% | 359.43% |
| Income Tax Expenses | 42.68% | 68.21% | 77.00% | 23.48% | -112.57% |
| Earnings from Continuing Operations | -79.34% | 33.19% | 722.25% | 475.69% | 371.27% |
| Earnings from Discontinued Operations | -- | 31.52% | 938.64% | 1,677.09% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -146.76% | -146.88% | -121.50% | -100.10% |
| Net Income | -81.69% | 40.43% | 671.41% | 485.87% | 392.44% |
| EBIT | 58.39% | 65.07% | 75.23% | 65.19% | 56.97% |
| EBITDA | 279.97% | 173.82% | 132.34% | 107.97% | 90.39% |
| EPS Basic | -81.68% | 40.24% | 671.15% | 487.10% | 392.75% |
| Normalized Basic EPS | 61.02% | 36.54% | 16.50% | 7.27% | -0.85% |
| EPS Diluted | -98.50% | 58.02% | 342.31% | 267.10% | 228.50% |
| Normalized Diluted EPS | 69.05% | 55.17% | 49.51% | 38.18% | 28.21% |
| Average Basic Shares Outstanding | 0.24% | 0.12% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 86.05% | 75.21% | 58.07% | 58.07% | 58.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |